Clinical Trials Sponsored by Histogen

Total 22 results

Histogen

Completed

Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension (ENCORE-PH)

Cirrhosis | Portal Hypertension | Non-alcoholic Steatohepatitis

United States, Germany, Spain
Histogen

Terminated

Safety and Tolerability of Emricasan in Symptomatic Outpatients Diagnosed With Mild-COVID-19

Covid19

United States
Histogen

Completed

Safety and Efficacy of HST 001 in Male Pattern Hair Loss

Male Pattern Hair Loss

United States
Histogen

Unknown

Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Pattern Hair Loss

Alopecia

United States
Histogen
Gleneagles CRC Pte Ltd.

Unknown

Safety and Efficacy of Hair Stimulating Complex (HSC) on Hair Growth in Males With Androgenetic Alopecia (HSC Phase I/II)

Androgenetic Alopecia

Philippines
Histogen
United States Department of Defense

Terminated

Human ECM Implanted Within Microfracture Interstices & the Cartilage Defect in the Knee to Regenerate Hyaline Cartilage (hECM;HST003)

Cartilage Damage | Articular Cartilage Disorder of Knee | Microfractures

United States
VistaGen Therapeutics, Inc.

Completed

PH94B in the Treatment of Adjustment Disorder With Anxiety

Adjustment Disorder With Anxious Mood

United States
VistaGen Therapeutics, Inc.

Terminated

PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge - 2 (Palisade-2)

Social Anxiety Disorder

United States
VistaGen Therapeutics, Inc.

Not yet recruiting

AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesia

Parkinson Disease | Dyskinesia, Medication-Induced | L-Dopa Causing Adverse Effects in Therapeutic Use
HitGen Inc.

Recruiting

Clinical Trial of HG146 Administered to Subjects With Advanced Solid Tumors or Lymphoma

Lymphoma | Solid Tumor

China
HitGen Inc.

Terminated

A Study of HG146 Capsule in Chinese Subjects With Relapsed and Refractory Multiple Myeloma

Multiple Myeloma | Relapsed and Refractory Multiple Myeloma

China
HitGen Inc.

Recruiting

A Study of HG381 Administered to Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
VistaGen Therapeutics, Inc.

Recruiting

Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3) (PALISADE-3)

Social Anxiety Disorder

United States
VistaGen Therapeutics, Inc.

Terminated

Open-label Safety Trial of PH94B in Social Anxiety Disorder (SAD)

Social Anxiety Disorder

United States
VistaGen Therapeutics, Inc.

Completed

PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge (Palisade-1)

Social Anxiety Disorder

United States
VistaGen Therapeutics, Inc.

Completed

AV-101 as Adjunct Antidepressant Therapy in Patients With Major Depression (ELEVATE)

Major Depressive Disorder

United States
VistaGen Therapeutics, Inc.
Parexel

Recruiting

AV-101 Alone and in Combination With Probenecid in Healthy Subjects

Drug Drug Interaction

United States
HealthEast Care System
Chitogen, Inc.

Completed

Heart and Hands Study II: A Retrospective Data Collection & Analysis Project

Thrombosis

United States
Aurora Health Care
Chitogen, Inc.

Completed

RAVE: Radial Artery Vascular Complication and Resource Utilization

Percutaneous Coronary Intervention | Angiogram

United States
VistaGen Therapeutics, Inc.
National Institute on Drug Abuse (NIDA); Cato Research

Completed

Safety, Tolerability and Pharmacokinetics of Multiple Doses of AV-101 in Healthy Volunteers

Neuropathic Pain

United States
Marijn Lijffijt, PhD
Michael E. DeBakey VA Medical Center; VistaGen Therapeutics, Inc.

Completed

Electrophysiological Biomarkers of AV-101

Healthy

United States
Universitaire Ziekenhuizen KU Leuven
KU Leuven; Hospital Clinic of Barcelona; MDx Health; Biomedical Research Foundation... and other collaborators

Not yet recruiting

Prospective Collection of Samples for Urothelial Cancer of Bladder (ProCSUCaB)

Bladder Cancer

Clinical Trials Sponsored by Histogen

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations